R
Roland E. Schmieder
Researcher at University of Erlangen-Nuremberg
Publications - 780
Citations - 85811
Roland E. Schmieder is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Blood pressure & Essential hypertension. The author has an hindex of 97, co-authored 717 publications receiving 78138 citations. Previous affiliations of Roland E. Schmieder include Complutense University of Madrid & University of Regensburg.
Papers
More filters
Journal ArticleDOI
Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial
Stefan John,Daniela Griesbach,Mathias Baumgärtel,Horst Weihprecht,Roland E. Schmieder,Helmut Geiger +5 more
TL;DR: Despite different changes of systemic haemodynamics between CVVH and IHD,CVVH did not improve parameters of splanchnic regional perfusion like pHi, pCO(2)i or pCO (2) gap in septic shock patients.
Journal ArticleDOI
Accuracy of Cuff-Measured Blood Pressure: Systematic Reviews and Meta-Analyses
Dean S. Picone,Martin G. Schultz,Petr Otahal,Svend Aakhus,Ahmed M. Al-Jumaily,J. Andrew Black,J. Andrew Black,Willem Jan W. Bos,John C. Chambers,Chen Huan Chen,Hao Min Cheng,Antoine Cremer,Justin E. Davies,Nathan Dwyer,Nathan Dwyer,Brian Gould,Alun D. Hughes,Peter S. Lacy,Esben Laugesen,Fuyou Liang,Roman Melamed,Sandy Muecke,Nobuyuki Ohte,Sho Okada,Stefano Omboni,Christian Ott,Xiaoqing Peng,Telmo Pereira,Giacomo Pucci,Ronak Rajani,Philip Roberts-Thomson,Philip Roberts-Thomson,Niklas B. Rossen,Daisuke Sueta,Manish D. Sinha,Roland E. Schmieder,Harold Smulyan,Velandai Srikanth,Velandai Srikanth,Ralph A.H. Stewart,George A. Stouffer,Kenji Takazawa,Ji-Guang Wang,Berend E. Westerhof,Franz Weber,Thomas C. Weber,Bryan Williams,Hirotsugu Yamada,Eiichiro Yamamoto,James E. Sharman +49 more
TL;DR: Cuff BP has variable accuracy for measuring either brachial or aortic intra-arterial BP, and this adversely influences correct BP classification, indicating that stronger accuracy standards for BP devices may improve cardiovascular risk management.
Journal ArticleDOI
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.
Felix Mahfoud,Michael Böhm,Michel Azizi,Atul Pathak,Isabelle Durand Zaleski,Sebastian Ewen,Kostantinos Tsioufis,Bert Andersson,Peter J. Blankestijn,Michel Burnier,Gilles Chatellier,Sameer Gafoor,Guido Grassi,Michael Joner,Sverre E. Kjeldsen,Sverre E. Kjeldsen,Thomas F. Lüscher,Melvin D. Lobo,Chaim Lotan,Gianfranco Parati,Josep Redon,Luis M. Ruilope,Isabella Sudano,Christian Ukena,Evert van Leeuwen,Massimo Volpe,Stephan Windecker,Adam Witkowski,William Wijns,Thomas Zeller,Roland E. Schmieder +30 more
TL;DR: Clinical evidence in support of RDN as an effective interventional technique in patients with resistant hypertension is conflicting; a number of observational studies and three randomized, controlled trials support both safety and efficacy of this new therapy but some smaller studies and the large, single-blind, randomized, sham-controlled symplicity HTN-3 trial failed to show superiority ofRDN when compared with medical therapy alone.
Journal ArticleDOI
Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)
Giuseppe Mancia,Helmut Schumacher,Josep Redon,Paolo Verdecchia,Roland E. Schmieder,Garry L. Jennings,Khalid Yusoff,Lars Rydén,G. Lisheng Liu,Koon K. Teo,Peter Sleight,Salim Yusuf +11 more
TL;DR: Overall, CV protection was favorably affected by the less tight but not by the tighter BP target, and the more frequent achievement of the BP targets led to cerebrovascular and renal protection, but did not increase cardiac protection.
Journal ArticleDOI
Salt and Hypertension: Is Salt Dietary Reduction Worth the Effort?
TL;DR: Dietary salt intake reduction can delay or prevent the incidence of antihypertensive therapy, can facilitate blood pressure reduction in hypertensive patients receiving medical therapy, and may represent a simple cost-saving mediator to reduce cardiovascular morbidity and mortality.